Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody

Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody

US Patent 12215147 · Granted Feb 4, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Variants of TNFSF15 and DCR3 associated with Crohn's disease2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Kit comprising contiguous nucleobases, including position 76, of RS57459942024
Kit comprising contiguous nucleobases, including position 76, of RS57459942024